CRISPR Therapeutics (CRSP) PT Raised to $84 at Needham & Company
Needham & Company analyst Alan ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
